BackOrion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Overview

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Total Liabilities

Track Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s total liabilities ($8.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$8.33M
44.88% YoYΔ $-6.79M vs prior year quarter

Peer average / median

Loading

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Total Liabilities History

Loading

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) vs. peers: Total Liabilities Comparison

Loading

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) (ORIAU) FAQ

As of the most recent data (December 2022), ORIAU shows a total liabilities of $8.3M. That compares with $15M in the prior-year period — down 44.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORIAU's total liabilities is now $8.3M (was $15M) — a 44.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) is outperforming or lagging.

Tracking ORIAU's total liabilities over time shows whether Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $8.3M That compares with $15M in the prior-year period — down 44.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $8.3M) with ownership activity and broader fundamentals.